Repligen Corporation $RGEN Stock Sold by Krilogy Financial LLCDefense World · Oct 15, 2026
Repligen: A Buy As Its Growth Engine Gears UpSeeking Alpha · Oct 14, 2026
Repligen to Report Third Quarter 2026 Financial ResultsGlobeNewsWire · Oct 13, 2026
Repligen Corp (RGEN) Shares Fall 7.7% -- What GF Score of 85 Tells InvestorsGuruFocus · Oct 6, 2026
Repligen Completes Acquisition of BioLife SolutionsGlobeNewsWire · Oct 6, 2026
Repligen Corp (RGEN) Stock Up 4.3% but GF Value Says Overvalued -- GF Score: 85/100GuruFocus · Oct 5, 2026Repligen Corporation specializes in the creation and distribution of advanced bioprocessing technologies and integrated systems. These solutions are vital for various stages of biological drug production, serving clients across North America, Europe, the Asia Pacific region, and other international markets. The company's diverse product portfolio includes crucial components for biomanufacturing.
| Date | Est. | Actual | |
|---|---|---|---|
| Jul 28, 2026 | $0.45 | $0.54 | Beat |
| May 5, 2026 | $0.38 | $0.48 | Beat |
| Feb 24, 2026 | $0.44 | $0.49 | Beat |
| Oct 28, 2025 | $0.42 | $0.46 | Beat |
| Jul 29, 2025 | $0.40 | $0.37 | Miss |
| Apr 29, 2025 | $0.35 | $0.39 | Beat |